Cargando…

Emerging evidence of immunotherapy for colorectal cancer

Since the advent of immune checkpoint inhibitors, which modulate the interplay between the tumor cell and immune system, immunotherapy has become widely recognized as a new standard treatment for cancers including microsatellite instability‐high (MSI‐H) colorectal cancer. Immune checkpoint inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyamoto, Yuji, Ogawa, Katsuhiro, Ohuchi, Mayuko, Tokunaga, Ryuma, Baba, Hideo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043776/ https://www.ncbi.nlm.nih.gov/pubmed/36998297 http://dx.doi.org/10.1002/ags3.12633

Ejemplares similares

Precision medicine for adjuvant chemotherapy of resected colorectal cancer
por: Miyamoto, Yuji, et al.
Publicado: (2020)

Negative Impact of Skeletal Muscle Loss after Systemic Chemotherapy in Patients with Unresectable Colorectal Cancer
por: Miyamoto, Yuji, et al.
Publicado: (2015)

Investigation of colorectal cancer in accordance with consensus molecular subtype classification
por: Sawayama, Hiroshi, et al.
Publicado: (2020)

Pathologic complete response after laparoscopic surgery following treatment with nivolumab and ipilimumab for anticancer drug-resistant MSI-high descending colon cancer: a case report and literature review
por: Sawayama, Hiroshi, et al.
Publicado: (2022)

Preoperative skeletal muscle status is associated with tumor‐infiltrating lymphocytes and prognosis in patients with colorectal cancer
por: Daitoku, Nobuya, et al.
Publicado: (2022)

Activin A promotes cell proliferation, invasion and migration and predicts poor prognosis in patients with colorectal cancer
por: Daitoku, Nobuya, et al.
Publicado: (2022)

Evaluation of clinical outcomes with propensity‐score matching for colorectal cancer presenting as an oncologic emergency
por: Ogawa, Katsuhiro, et al.
Publicado: (2022)

The advanced lung cancer inflammation index is a novel independent prognosticator in colorectal cancer patients after curative resection
por: Horino, Taichi, et al.
Publicado: (2021)

Ongoing 5-year+ survival after multiple metastasectomies, followed by CAPOX plus bevacizumab, for metastatic colorectal cancer
por: Matsuishi, Kozue, et al.
Publicado: (2020)

Repeated intestinal perforations in vascular Ehlers-Danlos syndrome: a case report of a novel mutation in the COL3A1 gene
por: Horino, Taichi, et al.
Publicado: (2023)

Prognostic and clinical impact of PIK3CA mutation in gastric cancer: pyrosequencing technology and literature review
por: Harada, Kazuto, et al.
Publicado: (2016)

Recent Advances in Targeting the EGFR Signaling Pathway for the Treatment of Metastatic Colorectal Cancer
por: Miyamoto, Yuji, et al.
Publicado: (2017)

Overall survival after recurrence in stage I–III colorectal cancer patients in accordance with the recurrence organ site and pattern
por: Sawayama, Hiroshi, et al.
Publicado: (2021)

Cancer-related multiple brain infarctions caused by Trousseau syndrome in a patient with metastatic colon cancer: a case report
por: Akiyama, Takahiko, et al.
Publicado: (2016)

Efficacy of delayed primary closure with intrawound continuous negative pressure and irrigation treatment after surgery for colorectal perforation
por: Ogawa, Katsuhiro, et al.
Publicado: (2021)

Essential updates 2020/2021: Colorectal diseases (benign)—Current topics in the surgical and medical treatment of benign colorectal diseases
por: Sawayama, Hiroshi, et al.
Publicado: (2022)

Rectal cancer diagnosed after resection of isolated brain metastasis
por: Tagayasu, Yoshiyuki, et al.
Publicado: (2022)

Immune-related adverse events and prognosis in patients with upper gastrointestinal cancer treated with nivolumab
por: Hara, Yoshihiro, et al.
Publicado: (2022)

A case of clinical stage I gastric cancer with a schwannoma on the left supraclavicular fossa suspected as Virchow’s node metastasis
por: Hara, Yoshihiro, et al.
Publicado: (2022)

Laparoscopic surgery for colorectal cancer with persistent descending mesocolon
por: Hiyoshi, Yukiharu, et al.
Publicado: (2019)

Emerging Role of Immunotherapy for Colorectal Cancer with Liver Metastasis
por: Yu, Xianzhe, et al.
Publicado: (2020)

IgG4-related disease presenting as a submucosal tumor of the stomach resected with laparoscopic endoscopic cooperative surgery: a case report
por: Yamane, Taishi, et al.
Publicado: (2020)

Appendiceal bleeding in an elderly male: a case report and a review of the literature
por: Maeda, Yuto, et al.
Publicado: (2021)

Current and Emerging Targets in Immunotherapy for Osteosarcoma
por: Miwa, Shinji, et al.
Publicado: (2019)

Immunotherapy for Colorectal Cancer
por: Boland, Patrick M., et al.
Publicado: (2017)

Synchronous NET and colorectal cancer development: a case report
por: Yumoto, Shinsei, et al.
Publicado: (2020)

Preoperative transferrin level is a novel prognostic marker for colorectal cancer
por: Sawayama, Hiroshi, et al.
Publicado: (2021)

CD169 (+) sinus macrophages in regional lymph nodes do not predict mismatch‐repair status of patients with colorectal cancer
por: Saito, Yoichi, et al.
Publicado: (2023)

A case of internal hernia in the pararectal fossa
por: Matsuishi, Kozue, et al.
Publicado: (2023)

Exploring immunotherapy in colorectal cancer
por: Weng, Junyong, et al.
Publicado: (2022)

Immunotherapy, Inflammation and Colorectal Cancer
por: Lichtenstern, Charles Robert, et al.
Publicado: (2020)

Combinatorial Immunotherapies for Metastatic Colorectal Cancer
por: Janssen, Eline, et al.
Publicado: (2020)

Emerging Trends in Immunotherapy for Cancer
por: Mishra, Alok K., et al.
Publicado: (2022)

Carbohydrate antigen 19-9 is a useful prognostic marker in esophagogastric junction adenocarcinoma
por: Tokunaga, Ryuma, et al.
Publicado: (2015)

Fibroblast growth factor receptor 2 expression, but not its genetic amplification, is associated with tumor growth and worse survival in esophagogastric junction adenocarcinoma
por: Tokunaga, Ryuma, et al.
Publicado: (2016)

Immune checkpoints and immunotherapy for colorectal cancer
por: Singh, Preet Paul, et al.
Publicado: (2015)

Where Is the “Optimal” Fontan Hemodynamics?
por: Ohuchi, Hideo
Publicado: (2017)

Tumor immune microenvironment and immune checkpoint inhibitors in esophageal squamous cell carcinoma
por: Baba, Yoshifumi, et al.
Publicado: (2020)

The Immunotherapy for Colorectal Cancer, Lung Cancer and Pancreatic Cancer
por: Chen, Shiu-Jau, et al.
Publicado: (2021)

Dendritic Cell-Based Immunotherapies and their Potential use in Colorectal Cancer Immunotherapy
por: Aldahlawi, Alia M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cq6k8r3srt8jt9ld6ojmcih83j